Cancer suicide gene therapy: a patent review

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2016;66(1):7–30.
   PubMed Web of Science ®Google Scholar
• Malecki M. Frontiers in suicide gene therapy of cancer. J Genet Syndr Gene Ther. 2012;22: pii: e114.
   Google Scholar
• Karjoo Z, Chen X, Hatefi A. Progress and problems with the use of suicide genes for targeted cancer therapy. Adv Drug Deliv Rev. 2016;99(Pt A):113–128.
   PubMed Web of Science ®Google Scholar
• Levy JP, Reed RA, Mcnulty J, et al. Improved thymidine kinase gene. WO 2014153258. 2014.
   Google Scholar
• Sung YC, Kim SW, Kim SJ, et al. Vector simultaneously expressing dodecameric trail and hsv-tk suicide genes, and anticancer stem cell therapeutic agent using same. US 20140369979. 2014.
   Google Scholar
• Parker WB, Sorscher EJ Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs. US8628767. 2014.
   Google Scholar
• Gruber HE, Jolly DJ, Perez OD, et al. Gene therapy vectors and cytosine deaminases. US 20140242033. 2014.
   Google Scholar
• Marais R, Springer C, Tommasini S Vaccinia virus for gene-directed enzyme prodrug therapy. WO2014202977. 2014.
   Google Scholar
• Waxman DJ, Chen L Cytochrome p450 reductase for the enhancement of p450-based anti-cancer gene therapy. EP1017835. 2011.
   Google Scholar
• Rojo MI, Barreras VGE, Gargini R Synergistic effect between a cyanogenic system and another oxidative inducing system for treating tumors. US20100028366. 2010.
   Google Scholar
• Recombinant beta-lactamase-RGD-fusion protein and application thereof in medicine. N101824406. 2010.
   Google Scholar
• Minton N, Anlezark G, Vaughan T Nitroreductase enzymes. US20040014191. 2004.
   Google Scholar
• Zhu Z Regulation of human carboxypeptidase A. WO2002052020. 2003.
   Google Scholar
• Salvatori F, Massa S, Radrizzani M, et al. Thymidine kinase. US20140178345. 2014.
   Google Scholar
• DeBenedetti A, DeFatta RJ Cancer gene therapy based on translational control of a suicide gene. US7592320. 2009.
   Google Scholar
• Erbs P Polypeptide having an improved cytosine deaminase activity. US20100330031. 2010.
   Google Scholar
• Shen JY, Laquerre S, Delaney AM, et al. Candida kefyr cytosine deaminase. WO2004061079. 2004.
   Google Scholar
• Altaner C. Prodrug cancer gene therapy. Cancer Lett. 2008;270(2):191–201.
   PubMed Web of Science ®Google Scholar
• Hanenberg H, Wiek C, Kramm C, et al. Cytochrome p450 suicide gene system. WO2013178635. 2013.
   Google Scholar
• Brown SM, Dunn P Oncolytic herpes simplex virus encoding a heterologous nitroreductase. WO2005049845. 2005.
   Google Scholar
• Culver KW, Blaese RM Bystander effect tumoricidal therapy by expressing an HSV-tk gene. US6045789A. 2000.
   Google Scholar
• Lin B, Gao A, Zhang R, et al. Use of a novel integrase-deficient lentivirus for targeted anti-cancer therapy with survivin promoter-driven diphtheria toxin A. Medicine (Baltimore). 2015;94(31):e1301.
   PubMed Web of Science ®Google Scholar
• Rodriguez R, Chowdhury WH Packaging cell line for diphtheria toxin expressing non-replicating adenovirus. US7582290. 2009.
   Google Scholar
• Kim CW, Yang WS, Kim MK Recombinant adenovirus expressing a gene encoding streptolysin o protein and anti-cancer composition comprising same. US20080286238. 2008.
   Google Scholar
• Kaufman H, Ruby C, Shafikhani S Pseudomonas exotoxins for cancer treatment. WO 2014150179. 2014.
   Google Scholar
• Otsuka Y. Prokaryotic toxin-antitoxin systems: novel regulations of the toxins. Curr Genet. 2016;62(2):379–382.
   PubMed Web of Science ®Google Scholar
• Inouye M, Inoue K Antitoxin destabilization technology. US 20100196951. 2010.
   Google Scholar
• Boulaiz H, Aranega A, Caceres B, et al. A novel double-enhanced suicide gene therapy in a colon cancer cell line mediated by gef and apoptin. BioDrugs. 2014;28(1):63–74.
   PubMed Web of Science ®Google Scholar
• Prados J, Melguizo C, Ortiz R, et al. Gene E for antitumour treatment. WO2009133220. 2009.
   Google Scholar
• Rohn JL, Zhang YH, Aalbers RI, et al. A tumor-specific kinase activity regulates the viral death protein Apoptin. J Biol Chem. 2002;277(52):50820–50827.
   PubMed Web of Science ®Google Scholar
• Noteborn MHM, Rohn JL, Mumberg D, et al. Modifications of apoptin. US7319034. 2008.
   Google Scholar
• Noteborn MHM Methods and uses for apoptin. CA2221495. 2010.
   Google Scholar
• Kandioler D Response prediction in cancer treatment (p53 adapted cancer therapy). WO2012093155. 2012.
   Google Scholar
• Peng ZSBC, Zhang X Recombined adenovirus p53 preparation for treating tumor. EP1842921. 2011.
   Google Scholar
• Li Y, Li B, Li CJ, et al. Key points of basic theories and clinical practice in rAd-p53 (Gendicine) gene therapy for solid malignant tumors. Expert Opin Biol Ther. 2015;15(3):437–454.
   PubMed Web of Science ®Google Scholar
• Hu Y, Benedict MA, Wu D, et al. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci U S A. 1998;95(8):4386–4391.
   PubMed Web of Science ®Google Scholar
• Pinsky MS, Song W, Dong Z, et al. Activation of iCaspase-9 in neovessels inhibits oral tumor progression. J Dent Res. 2006;85(5):436–441.
   PubMed Web of Science ®Google Scholar
• Selkirk SM, Miller RH Targeted cell death. US20100299770. 2010.
   Google Scholar
• Liu Z, Ding Y, Ye N, et al. Direct activation of bax protein for cancer therapy. Med Res Rev. 2016;36(2):313–341.
   PubMed Web of Science ®Google Scholar
• Reed JC Methods of using Bcl-2 for the therapeutic treatment and prevention of diseases. US7427495. 2008.
   Google Scholar
• McDonnell T, Swisher S, Fang B, et al. Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery. US20060002895. 2006.
   Google Scholar
• Shore GC, Goping IS Bax-mediated apoptosis modulating reagents and methods. US6245885. 2001.
   Google Scholar
• Kazhdan I Methods and compositions for combinatorial approaches to cancer gene therapy. WO2005049793. 2005.
   Google Scholar
• Gregory RJ, Wills KN, Maneval DC Recombinant adenoviral vectors and methods of use. US2009088398. 2009.
   Google Scholar
• Meruelo D, Tseng JC Tumor therapy with replication competent sindbis viral vectors. US2013137754. 2013.
   Google Scholar
• Zeng Q, Xue Z Liver cancer suicide gene therapy medicine based on aminated silicon dioxide nanoparticle-CD/TK (cytosine deaminase-thymidine kinase) fused gene compound. CN103357024. 2013.
   Google Scholar
• Castillo R, De Lourdes ES, Martínez F Nts-polyplex nanoparticles system for gene therapy of cancer. WO2012107908. 2012.
   Google Scholar
• Segovia V, Mejía C, Tellez L, et al. Nanoparticle gene system with apoptotic effect with tumor specificity for cancer therapy. WO2015177775. 2016.
   Google Scholar
• Li G, Lee YW, Lau PY Cell-mediated gene therapy for cancer using mesenchymal stem cells expressing a suicide gene. US2013171115. 2013.
   Google Scholar
• Orrichio E, Wendel HG Cancer-specific suicide gene for cell-based and gene therapy. US2015299278. 2015.
   Google Scholar
• Aránega J, Boulaiz T, Cáceres G, et al. Polynucleotide containing the gef and apoptin genes, and the use thereof in gene therapy for colon cancer. WO2015011332. 2015.
   Google Scholar
• Ran LH, Park KR, Jeong SJ, et al. Synthetic human telomerase reverse transcriptase promoter enhancing gene expression. KR1020070114520. 2007.
   Google Scholar
• Bi-target treatment for bladder cancer by non-fusion Adeno-associated virus carrier of tumstatin Tumstatin and suicide gene HSV-TK. CN101810865. 2010.
   Google Scholar
• Woo SLC, Chen SH Gene therapy for solid tumors using adenoviral vectors comprising suicide genes and cytokine genes. US6066624. 2000.
   Google Scholar
• Clarke M, Wicha M, Nunez G, et al. Gene therapy approaches to target cell death for cancer treatment: compositions and method. WO 1998030101. 1998.
   Google Scholar
• Meruelo D, Tseng JC Tumor therapy with replication competent sindbis viral vectors. US2013137754. 2009.
   Google Scholar
• Song JS Adenovirus vector with telomerase promoter, SV40 enhancer and the methods for anti-cancer treatments. KR20040002322 (A). 2005.
   Google Scholar
• Sigmund W, Bayar T, Leonard A Tissue specific adenovirus vectors for breast cancer treatment. US 6096718 A. 2000.
   Google Scholar
• Tagawa M Tumor-specific promoters. US20030157065. 2003.
   Google Scholar
• Tagawa M Tumor specific promoters of the midkine gene that allow for selective expression in P53-inactivated cells. US7030099. 2006.
   Google Scholar
• Gui W, Xia T, Zhiping W, et al. High tropism bladder cancer targeting tumor-killing adenovirus. CN104328140. 2015.
   Google Scholar
• Pahle J, Walther W. Vectors and strategies for nonviral cancer gene therapy. Expert Opin Biol Ther. 2016;16(4):443–461.
   PubMed Web of Science ®Google Scholar
• Cihova M, Altanerova V, Altaner C. Stem cell based cancer gene therapy. Mol Pharm. 2011;8(5):1480–1487.
   PubMed Web of Science ®Google Scholar
• Mason HS, Fan H, Bjorklund G Methods of protein production and compositions thereof. WO2012145759. 2015.
   Google Scholar
• Altanerova V, Cihova M, Babic M, et al. Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase:: uracilphosphoribosyltransferase inhibit intracerebral rat glioblastoma. Int J Cancer. 2012;130(10):2455–2463.
   PubMed Web of Science ®Google Scholar
• Altaner C, Altanerova V, Cihova M, et al. Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario. Cancer. 2014;134(6):1458–1465.
   Web of Science ®Google Scholar
• Altaner C. Prodrug gene therapy for cancer mediated by mesenchymal stem/stromal cells engineered to express yeast cytosinedeaminase: uracilphosphoribosyltransferase. J Stem Cell Res Ther. 2015;5:264.
   Google Scholar
• Boucher PD, Im MM, Freytag SO, et al. A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy. Cancer Res. 2006;66(6):3230–3237.
   PubMed Web of Science ®Google Scholar
• Teo PY, Cheng W, Hedrick JL, et al. Co-delivery of drugs and plasmid DNA for cancer therapy. Adv Drug Deliv Rev. 2016;98:41–63.
   PubMed Web of Science ®Google Scholar
• Ortiz R, Prados J, Melguizo C, et al. Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells. Biomed Pharmacother. 2012;66(7):563–567.
   PubMed Web of Science ®Google Scholar
• Sun X, Xing L, Deng X, et al. Hypoxia targeted bifunctional suicide gene expression enhances radiotherapy in vitro and in vivo. Radiother Oncol. 2012;105(1):57–63.
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Farzan M. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma. World J Gastroenterol. 2015;21(42):12022–12041.
   PubMed Web of Science ®Google Scholar
• Tophkhane C, Yang S, Bales W, et al. Bcl-2 overexpression sensitizes MCF-7 cells to genistein by multiple mechanisms. Int J Oncol. 2007;31(4):867–874.
   PubMed Web of Science ®Google Scholar
• Strauss JH, Wang KS, Schmaljohn AL, et al. Host-cell receptors for Sindbis virus. Arch Virol Suppl. 1994;9:473–484.
   PubMedGoogle Scholar
• Eichhorn JM, Alford SE, Sakurikar N, et al. Molecular analysis of functional redundancy among anti-apoptotic Bcl-2 proteins and its role in cancer cell survival. Exp Cell Res. 2014;322(2):415–424.
   PubMed Web of Science ®Google Scholar
• Fischer TJ, Groelke JW, Malinowski DP Nucleic acid-based methods for the detection of ovarian cancer. WO2009032974. 2009.
   Google Scholar
• Fukazawa T, Matsuoka J, Yamatsuji T, et al. Adenovirus-mediated cancer gene therapy and virotherapy (Review). Int J Mol Med. 2010;25(1):3–10.
   PubMed Web of Science ®Google Scholar
• Zhang C, Yao T, Zheng Y, et al. Development of next generation adeno-associated viral vectors capable of selective tropism and efficient gene delivery. Biomaterials. 2016;80:134–145.
   PubMed Web of Science ®Google Scholar
• Black ME Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities. WO9919466. 1999.
   Google Scholar
• Black ME Polynucleotides encoding thymidine kinase mutants. US2012149890. 2012.
   Google Scholar
• Kong H, Liu X, Yang L, et al. All-trans retinoic acid enhances bystander effect of suicide gene therapy in the treatment of breast cancer. Oncol Rep. 2016;35(3):1868–1874.
   PubMed Web of Science ®Google Scholar
• Kwiatkowska A, Nandhu MS, Behera P, et al. Strategies in gene therapy for glioblastoma. Cancers (Basel). 2013;5(4):1271–1305.
   PubMedGoogle Scholar
• Kenbaugh AL, Baldwin AS. The NF-kappaB pathway and cancer stem cells. Cells. 2016;5:2.
   Google Scholar
• Ysar SB, Jimeno A. More than markers: biological significance of cancer stem cell-defining molecules. Mol Cancer Ther. 2010;9(9):2450–2457.
   PubMed Web of Science ®Google Scholar
• Huszthy PC, Giroglou T, Tsinkalovsky O, et al. Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy. PLoS One. 2009;4(7):e6314.
   PubMed Web of Science ®Google Scholar
• Hu W, Liu W. Side populations of glioblastoma cells are less sensitive to HSV-TK/GCV suicide gene therapy system than the non-side population. Vitro Cell Dev Biol Anim. 2010;46(6):497–501.
   PubMed Web of Science ®Google Scholar